Roxadustat
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Anemia Associated With End Stage Renal Disease (ESRD)
Conditions
Anemia Associated With End Stage Renal Disease (ESRD)
Trial Timeline
May 26, 2020 → Oct 11, 2021
NCT ID
NCT04410198About Roxadustat
Roxadustat is a phase 3 stage product being developed by AstraZeneca for Anemia Associated With End Stage Renal Disease (ESRD). The current trial status is completed. This product is registered under clinical trial identifier NCT04410198. Target conditions include Anemia Associated With End Stage Renal Disease (ESRD).
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04621331 | Phase 3 | Withdrawn |
| NCT04484857 | Phase 3 | Completed |
| NCT04410198 | Phase 3 | Completed |
Competing Products
20 competing products in Anemia Associated With End Stage Renal Disease (ESRD)
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Aranesp® | Amgen | Approved | 84 |
| KER-047 | Keros Therapeutics | Phase 2 | 44 |
| LY2787106 | Eli Lilly | Phase 1 | 33 |
| R744 + R744 | Chugai Pharmaceutical | Phase 3 | 77 |
| epoetin beta + placebo | Chugai Pharmaceutical | Phase 3 | 77 |
| recombinant human erythropoietin + recombinant human erythropoietin placebo | Chugai Pharmaceutical | Phase 3 | 77 |
| recombinant human erythropoietin + recombinant human erythropoietin | Chugai Pharmaceutical | Phase 3 | 77 |
| darbepoetin alfa | Amgen | Phase 3 | 76 |
| Prasugrel | Daiichi Sankyo | Phase 1 | 33 |
| Prasugrel + Placebo | Daiichi Sankyo | Phase 2 | 52 |
| roxadustat | Astellas Pharma | Phase 3 | 77 |
| roxadustat | Astellas Pharma | Phase 3 | 77 |
| Roxadustat + Darbepoetin alfa | Astellas Pharma | Phase 3 | 77 |
| Alefacept | Astellas Pharma | Phase 1 | 33 |
| Roxadustat | Astellas Pharma | Phase 2 | 52 |
| roxadustat | Astellas Pharma | Phase 1 | 33 |
| Roxadustat + Placebo | Astellas Pharma | Phase 3 | 77 |
| Roxadustat | Astellas Pharma | Pre-clinical | 23 |
| Roxadustat + Epoetin Alfa | Astellas Pharma | Phase 3 | 77 |
| roxadustat + Darbepoetin alfa | Astellas Pharma | Phase 3 | 77 |